Those used in the UK as effective at preventing symptomatic disease in the majority of people with underlying health conditions as the rest of the population. Category: UncategorisedBy 10 July 2021Leave a commentPost navigationPreviousPrevious post:Guidance: Vaccine incident guidance: responding to vaccine errorsNextNext post:Research: Be Clear on Cancer: first national ‘Cervical Screening Saves Lives’ campaign
